Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic HIV medication in the US market. The company has received tentative approval from the US ...

Lupin has a strong pipeline of more than 20 respiratory products and 40 injectable products in the development stage to leverage its market presence. It plans to file over 30 abbreviated new drug ...